- Open
- 76.00
- High
- 77.30
- Low
- 76.00
- Close
- 76.90
- Change
- +0.80 (1.05%)
- Volume
- 903,462
| 30 Jun 2026 | 07:00:05 | Half-year Financial Report |
| 15 Jun 2026 | 14:42:06 | Holding(s) in Company |
| 18 May 2026 | 16:11:36 | Director/PDMR Shareholding |
| 12 May 2026 | 10:11:44 | Director/PDMR Shareholding |
| 22 Dec 2025 | Annual Report & Financial Statements for the year ended 30 September 2025 | |
| 3 Apr 2025 | Annual Report & Financial Statements for the year ended 30 September 2024 | |
| 1 Jan 2024 | Chrysalis Investments Limited Annual Report 2023 |
Chrysalis Investments aims to achieve long-term capital growth by investing in a diverse range of equity or equity-related investments.
| 30 Jun 2026 | 07:00:05 | Half-year Financial Report |
| 15 Jun 2026 | 14:42:06 | Holding(s) in Company |
| 18 May 2026 | 16:11:36 | Director/PDMR Shareholding |
| 12 May 2026 | 10:11:44 | Director/PDMR Shareholding |
| 22 Dec 2025 | Annual Report & Financial Statements for the year ended 30 September 2025 | |
| 3 Apr 2025 | Annual Report & Financial Statements for the year ended 30 September 2024 | |
| 1 Jan 2024 | Chrysalis Investments Limited Annual Report 2023 |
Chrysalis Investments aims to achieve long-term capital growth by investing in a diverse range of equity or equity-related investments.
| 7 May 2026 |
| 11:38:35 |
| Director/PDMR Shareholding |
| 26 Jun 2026 |
| Discount Delver: the 10 cheapest trusts on 26 June 2026 |
| 5 May 2026 | Morning briefing: March sell-off knocks 17% off Chrysalis; Patria halves its stake in 3is Action; Zenos nuclear battery beats expectations, says Seraphim |
| 3 Sept 2025 | Klarna chooses New York for $14bn IPO |
Jack Rankin has interests in this issuer
| 7 May 2026 |
| 11:38:35 |
| Director/PDMR Shareholding |
| 26 Jun 2026 |
| Discount Delver: the 10 cheapest trusts on 26 June 2026 |
| 5 May 2026 | Morning briefing: March sell-off knocks 17% off Chrysalis; Patria halves its stake in 3is Action; Zenos nuclear battery beats expectations, says Seraphim |
| 3 Sept 2025 | Klarna chooses New York for $14bn IPO |
Jack Rankin has interests in this issuer
